DaVita Announces Woodard Qui Tam Settlement
DENVER--(BUSINESS WIRE)--Jul. 3, 2012-- DaVita Inc. (NYSE: DVA) today announced that it has reached an agreement in principle regarding all claims arising out of the previously disclosed...
DENVER--(BUSINESS WIRE)--Jul. 3, 2012-- DaVita Inc. (NYSE: DVA) today announced that it has reached an agreement in principle regarding all claims arising out of the previously disclosed...
MINNEAPOLIS--(BUSINESS WIRE)--Jun. 13, 2012-- DaVita Clinical Research® (DCR®), a provider of clinical research services focused on kidney research as well as a multitude of specialty...
DENVER--(BUSINESS WIRE)--Jun. 11, 2012-- DaVita Inc. (NYSE: DVA), a leading provider of kidney care services that is committed to improving the quality of life for those diagnosed with chronic...
DENVER--(BUSINESS WIRE)--Jun. 4, 2012-- DaVita Inc. (NYSE: DVA), a leading provider of kidney care services that is committed to improving the quality of life for those diagnosed with chronic...
DENVER--(BUSINESS WIRE)--Jun. 1, 2012-- DaVita Inc. (NYSE: DVA), a leading provider of kidney care services that is committed to improving the quality of life for those diagnosed with chronic...